康惠制药(603139.SH)：陕西友帮对1号、2号及3号车间全面停产

Core Viewpoint - Kanghui Pharmaceutical (603139.SH) is facing intensified market competition and declining product sales margins due to adverse industry conditions, leading to operational adjustments and production halts at its subsidiary Shaanxi Youbang [1] Company Summary - Kanghui Pharmaceutical's product sales gross margin has been continuously declining as a result of increased market competition [1] - Shaanxi Youbang plans to adjust its product offerings and has attempted to trial production of multiple new products; however, these efforts have been unsuccessful due to issues with production processes, equipment updates, and immature technology [1] - To mitigate further losses and protect shareholder interests, Shaanxi Youbang has decided to fully suspend production at workshops 1, 2, and 3, with future production resumption contingent on market conditions [1]